George L. Mulvey

发表

Intrarectal Instillation of Clostridium difficile Toxin A Triggers Colonic Inflammation and Tissue Damage: Development of a Novel and Efficient Mouse Model of Clostridium difficile Toxin Exposure

Yan Li, G. Armstrong, T. Dingle, 2012, Infection and Immunity.

Impact of the Nature and Size of the Polymeric Backbone on the Ability of Heterobifunctional Ligands to Mediate Shiga Toxin and Serum Amyloid P Component Ternary Complex Formation

G. Armstrong, R. Narain, Marya Ahmed, 2011, Toxins.

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

R. Read, G. Armstrong, N. Pannu, 2000, Nature.

Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2

R. Hancock, G. Armstrong, R. Humphries, 2011, PloS one.

Structural and evolutionary analyses show unique stabilization strategies in the type IV pili of Clostridium difficile.

Grace A Maldarelli, Kurt H Piepenbrink, G. Armstrong, 2015, Structure.

Interactions of Enteropathogenic Escherichia coli with Pediatric and Adult Intestinal Biopsy Specimens during Early Adherence

G. Armstrong, R. Humphries, C. Waterhouse, 2009, Infection and Immunity.

Structure of Clostridium difficile PilJ Exhibits Unprecedented Divergence from Known Type IV Pilins*

Grace A Maldarelli, Kurt H Piepenbrink, G. Armstrong, 2013, The Journal of Biological Chemistry.

BfpI, BfpJ, and BfpK Minor Pilins Are Important for the Function and Biogenesis of Bundle-Forming Pili Expressed by Enteropathogenic Escherichia coli

G. Armstrong, G. Mulvey, M. Donnenberg, 2015, Journal of bacteriology.

Differential binding of Shiga toxin 2 to human and murine neutrophils.

P. Marcato, G. Armstrong, G. Mulvey, 2007, Journal of medical microbiology.

Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

C. Sabin, P. Marcato, G. Armstrong, 2006, The Journal of infectious diseases.

N‐acetyllactosamine‐induced retraction of bundle‐forming pili regulates virulence‐associated gene expression in enteropathogenic Escherichia coli

M. Surette, G. Armstrong, R. Humphries, 2010, Molecular microbiology.

Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells

G. Armstrong, R. Hutkins, G. Mulvey, 2006, Infection and Immunity.

Glycan mimicry as a basis for novel anti-infective drugs.

P. Marcato, G. Armstrong, P. Kitov, 2001, Biochimie.

Recombinant Shiga Toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine Protects Mice from Shigatoxemia

P. Marcato, G. Armstrong, G. Mulvey, 2005, Infection and Immunity.

Synthesis and Structure − Activity Relationship Studies of N ‐ Terminal Analogues of the Antimicrobial Peptide Tridecaptin A 1

J. Vederas, G. Armstrong, G. Mulvey, 2014 .

Mutagenic Analysis of the Clostridium difficile Flagellar Proteins, FliC and FliD, and Their Contribution to Virulence in Hamsters

G. Armstrong, T. Dingle, G. Mulvey, 2011, Infection and Immunity.

N-Acetyllactosamine Conjugated to Gold Nanoparticles Inhibits Enteropathogenic Escherichia coli Colonization of the Epithelium in Human Intestinal Biopsy Specimens

G. Armstrong, P. Kitov, G. Mulvey, 2006, Infection and Immunity.

Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence.

P. Marcato, G. Armstrong, P. Kitov, 2006, Journal of medical microbiology.

In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the Escherichia coli O157 AB5 toxins

G. Armstrong, K. Yamamura, P. Kitov, 2008, Proceedings of the National Academy of Sciences.

Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands.

P. Marcato, G. Armstrong, P. Kitov, 2003, The Journal of infectious diseases.